LPCN
Price:
$2.26
Market Cap:
$13.12M
Lipocine Inc. is a biopharmaceutical firm currently in the clinical development phase, concentrating its efforts on creating medicinal products to address a range of neuroendocrine and metabolic conditions. A core aspect of the company's research and development involves formulating oral delivery methods for pharmaceutical compounds that typically suffer from low bioavailability. Its foremost investigational therapy is TLANDO, an oral solution for testosterone replacement. The company's development pipeline also encompasses several other promising candidates: LPCN 1144: An orally administered prodrug derived from bioidentical testosterone, which has successfully completed Phase II clinical t...[Read more]
Industry
Biotechnology
IPO Date
2013-10-22
Stock Exchange
NASDAQ
Ticker
LPCN
According to Lipocine Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 8.10M. This represents a change of -70.60% compared to the average of 27.55M of the last 4 quarters.
The mean historical Enterprise Value of Lipocine Inc. over the last ten years is 37.96M. The current 8.10M Enterprise Value has changed 2.03% with respect to the historical average. Over the past ten years (40 quarters), LPCN's Enterprise Value was at its highest in in the March 2022 quarter at 116.73M. The Enterprise Value was at its lowest in in the December 2019 quarter at 9.22M.
Average
37.96M
Median
34.60M
Minimum
7.39M
Maximum
65.53M
Discovering the peaks and valleys of Lipocine Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 730.75%
Maximum Annual Enterprise Value = 65.53M
Minimum Annual Increase = -75.15%
Minimum Annual Enterprise Value = 7.39M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 38.55M | 94.22% |
| 2024 | 19.85M | 99.87% |
| 2023 | 9.93M | -67.61% |
| 2022 | 30.66M | -44.26% |
| 2021 | 55.00M | -10.43% |
| 2020 | 61.41M | 730.75% |
| 2019 | 7.39M | -75.15% |
| 2018 | 29.74M | -54.61% |
| 2017 | 65.53M | 6.44% |
| 2016 | 61.57M | -67.95% |
The current Enterprise Value of Lipocine Inc. (LPCN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
22.78M
5-year avg
30.80M
10-year avg
37.96M
Lipocine Inc.’s Enterprise Value is less than OSR Holdings, Inc. (12.75M), less than Adaptimmune Therapeutics plc (31.10M), less than Adlai Nortye Ltd. (550.38M), less than BioLineRx Ltd. (20.89M), greater than GeoVax Labs, Inc. (292.14K), less than Edesa Biotech, Inc. (41.57M), greater than ProMIS Neurosciences, Inc. (-50281016.00), greater than Ernexa Therapeutics Inc. (-6856137.00), less than Lunai Bioworks Inc. (9.18M), greater than Moleculin Biotech, Inc. (3.96M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 12.75M | $9.36M | |
| 31.10M | $75.16M | |
| 550.38M | $547.79M | |
| 20.89M | $14.66M | |
| 292.14K | $1.17M | |
| 41.57M | $51.57M | |
| -50281016.00 | $13.53M | |
| -6856137.00 | $1.93M | |
| 9.18M | $10.93M | |
| 3.96M | $14.09M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lipocine Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Lipocine Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Lipocine Inc.'s Enterprise Value?
What is the highest Enterprise Value for Lipocine Inc. (LPCN)?
What is the 3-year average Enterprise Value for Lipocine Inc. (LPCN)?
What is the 5-year average Enterprise Value for Lipocine Inc. (LPCN)?
How does the current Enterprise Value for Lipocine Inc. (LPCN) compare to its historical average?